Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
12 May 2024 (12:00 - 12:45)
Organised by: 
About the speaker
Oslo University Hospital Rikshospitalet, Oslo (Norway)
4 More presentations in this session
Doctor D. Enriquez Vazquez (A Coruna, ES)
Doctor M. Flesvig Holt (Oslo, NO)
Ms E. Silver (La Jolla, US)
Access the full session
The Event
Heart Failure 2024
12 May 2024
12:00 CET
You may be interested in
Congress Presentation
